Association of plasma sPD‐1 and sPD‐L1 with disease status and future relapse in AQP4‐IgG (+) NMOSD
Abstract Objective Neuromyelitis optica spectrum disorder (NMOSD) is an autoimmune‐mediated disorder with aquaporin 4‐immunoglobulin G (AQP4‐IgG) in most settings. Soluble programmed death‐1 (sPD‐1) and soluble programmed death ligand 1 (sPD‐L1) play key roles in immunomodulation. We aim to assess t...
Main Authors: | Jia Liu, Xi Shao, Jingya Fan, Ying Wang, Yuanbo Cao, Guojun Tan, Kazuo Sugimoto, Bin Li, Zhen Jia |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-02-01
|
Series: | Annals of Clinical and Translational Neurology |
Online Access: | https://doi.org/10.1002/acn3.51964 |
Similar Items
-
Can sPD-1 and sPD-L1 Plasma Concentrations Predict Treatment Response among Patients with Extraparenchymal Neurocysticercosis?
by: Andrea Toledo, et al.
Published: (2023-09-01) -
sPD-1/sPD-L1 proteins in non-small cell lung cancer and esophageal squamous cell carcinoma
by: I. S. Stilidi, et al.
Published: (2022-10-01) -
Clinical Relevance of Soluble Forms of Immune Checkpoint Molecules sPD-1, sPD-L1, and sCTLA-4 in the Diagnosis and Prognosis of Ovarian Cancer
by: Janina Świderska, et al.
Published: (2022-01-01) -
Membrane (CD8⁺PD-1⁺ and CD4+PD-1⁺) and soluble (sPD-1 and sPD-L1) forms of immune checkpoints in melanoma, breast cancer, and oral mucosal cancer patients: A observational study
by: Tatiana N. Zabotina, et al.
Published: (2023-12-01) -
The association between sPD-1 levels versus liver biochemistry and viral markers in chronic hepatitis B patients: a comparative study of different sPD-1 assays
by: Wen-Juei Jeng, et al.
Published: (2022-03-01)